This new book, Macular Degeneration: A Progressive Retinal Disorder, provides an in-depth look at the various features of age-related macular degeneration (AMD). It provides a complete overview of this common retinal condition by focusing on the experience of ophthalmology and associated fields. The book explores the complex systems that drive AMD causes and pathology, as well as the most recent advances in diagnostic procedures and treatment plans. It also looks at genetic factors, inflammatory pathways, and the possibilities of artificial intelligence. It digs into AMD complexities, investigating its etiology, pathogenesis, diagnostic techniques, and developing therapy strategies.
The book bridges the gap between fundamental research and clinical applications, giving significant insights for ocular health researchers, physicians, educators, and students. It covers topics from molecular pathways to cutting-edge therapeutics, making it an invaluable resource for anybody interested in engaging in the study of AMD and improving patient care. The book goal is to increase understanding of AMD and motivate additional research and collaboration in the prevention, diagnosis, and treatment of this vision-threatening illness.
Providing a detailed compilation in an effort to understand the complexities of age-related macular degeneration, this volume will enlighten and encourage additional investigation, promoting a continual debate and collaboration in the never-ending effort of curing this difficult retinal illness.
Bhupendra Prajapati, PhD, is a Professor in the Department of Pharmaceutics at the Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India, and Adjunct Professor at Silpakorn University, Thailand. He has 22 years of academic and research experience and published more than 250 research and review works in international and national journals. He has delivered invited scientific talks at many conferences and seminars worldwide. He authored 150 book chapters in the field of novel drug delivery. He edited 20 books with publishers such as Elsevier, AAP CRC, Wiley, Springer, and Jenny Stanford. He is a reviewer for many high-impact journals and is an editorial board member of several journals as well.
Rishabha Malviya, PhD, has 12 years of research experience and is presently working as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India. His areas of interest include formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery, and characterization of natural polymers as pharmaceutical excipients. He has authored more than 150 research and review papers for national and international journals of repute. He holds over 50 patents and has published many papers in reputed national and international journals, for which he received an outstanding reviewer award from Elsevier. He has edited 13 books (Wiley, Springer Nature, CRC Press/Taylor and Francis, Apple Academic Press, River Publisher, Lambert, and OMICS Publishing Group) and authored 15 book chapters. His name has been included in the World Top 2% Scientists list by Elsevier BV and Stanford University. He is reviewer, editor, and editorial board member for more than 50 national and international journals. He was an invited author for the magazine Atlas of Science as well as a pharma magazine dealing with B2B industry, Ingredient South Asia. He completed his BPharm at Uttar Pradesh Technical University and MPharm (Pharmaceutics) at Gautam Buddha Technical University, Lucknow Uttar, India.
Himanshu Paliwal, PhD, is an Assistant Professor (Research) at the Marwadi University Research Center, Marwadi University, India. He completed his PhD at Bhupal Nobles' University, Udaipur, and pursued postdoctoral research at the Drug Delivery System Excellence Center, Prince of Songkla University, Thailand. With over nine years of experience in research and academia, Dr. Paliwal has published 32 research and review papers in peer-reviewed journals and contributed 13 book chapters with renowned publishing houses. He is a lifetime member of the Association of Pharmaceutical Teachers of India and has mentored 11 postgraduate research scholars. His current research focuses on lipid-based drug delivery systems and micellar solubilization for treating ocular, pulmonary diseases, and cancer.
Sonali Sundram, PhD, is Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, Greater Noida, Uttar Pradesh, India. Previously, she worked as a research scientist on a project of ICMR at King George Medical University, Lucknow, India. After that, she joined BBDNIIT (Babu Banarasi Das Northern India Institute of Technology), Lucknow. Her PhD (Pharmacy) work was in neurodegeneration and nanoformulation. Her areas of interest include neurodegeneration, clinical research, and artificial intelligence. She has authored or edited 14 books (Wiley, CRC Press/Taylor and Francis, River Publisher, IOP Publishing) and has organized more than 15 national and international seminars, conferences, and workshops. She has more than eight patents, both national and international, to her credit. She completed both BPharm and MPharm (Pharmacology) at Dr. A.P.J. Abdul Kalam Technical University, Lucknow, India.
